HaemaLogiX is delighted to be sharing the results of new pre-clinical data at the European Association of Hematology Congress, EHA2024, taking place this week in Madrid, Spain.
Read article +HaemaLogiX Ltd, a clinical stage biotech developing novel immunotherapies for patients with blood cancers and B-cell diseases, is pleased to announce the appointment of Professor the Hon Greg Hunt, former Federal Minister for Health, to the HaemaLogiX Board as a Non-Executive Director.
Read article +HaemaLogiX's CMDO, Tertia Dex will be speaking at the Women in BIO and Health – Industry and Networking Forum to be held on Wednesday 8 May 2024, at UniSC Moreton Bay, Petrie, Queensland.
Read article +Today, on Rare Disease Day, we reflect on the courage and resilience of those facing the challenges of rare medical conditions.
Read article +HaemaLogiX Ltd, a clinical stage biotech, is pleased to announce the appointment of Laurence Turka, M.D. to its board as a non-executive director.
Read article +